Gill John
- SEC CIK
- 0001409939
In the past year, 2 open-market purchase filings worth $82.6K and no sales.
Current role at each company
- ALT Altimmune, Inc.Directoras of May 1, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $82.6K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$82.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gill John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 (view filing) | Apr 6 | Same day | Gill JohnDirector | PPurchaseCommon Stock, par value $0.0001 | +9.20K | $3.41 | +$31.4K | +73.6%21.7K after | |
| Dec 23, 2025 (view filing) | Dec 23 | Same day | Gill JohnDirector | PPurchaseCommon Stock, par value $0.0001 | +12.5K | $4.10 | +$51.3K | New position12.5K after | |
| Jul 6, 2023 (view filing) | Aug 12, 2022 | 328 daysLate | Gill JohnDirector | SSaleCommon Stock, par value $0.0001 | −2.71K | $15.00 | −$40.7K | −49.5%2.77K after |